Physician profile
Mark Apfelbaum
NPI 1477630531
$2,510.92
in general payments reported to CMS, 2019-2025
16 companies · $377 in 2025
The $377 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $297 · 2021: $218 · 2022: $378 · 2023: $334 · 2024: $359 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $731.77 | 2019-2025 | Emblem Mri S-Icd, Accolade Sr, Ranger |
| Abbott Laboratories | $721.56 | 2019-2025 | Nc Trek Neo, Xience Skypoint |
| Abiomed | $170.12 | 2024-2025 | Impella |
| Biotronik INC. | $168.25 | 2022 | |
| Heartflow, INC. | $144.17 | 2025 | |
| Medtronic, INC. | $141.38 | 2021-2023 | Linq II, Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $127.15 | 2021 | |
| Medtronic Vascular, INC. | $95.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $38.51 | 2023 | Verquvo |
| Kestra Medical Technology Services, INC. | $34.25 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.47 | 2022-2023 | Jardiance |
| Penumbra, INC. | $28.82 | 2019 | |
| Davol INC. | $28.07 | 2025 | Venovo |
| Terumo Medical Corporation | $20.24 | 2025 | Glidewire |
| Astrazeneca Pharmaceuticals Lp | $15.33 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $14.11 | 2025 | Zilver Vena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Apfelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.